Go Pro

Privia Health Group (PRVA) Stock Price, News & Analysis

Privia Health Group logo
$20.42 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$20.66 +0.24 (+1.18%)
As of 05:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Privia Health Group Stock (NASDAQ:PRVA)

Advanced

Key Stats

Today's Range
$20.28
$20.70
50-Day Range
$20.37
$28.10
52-Week Range
$19.53
$28.82
Volume
925,299 shs
Average Volume
981,927 shs
Market Capitalization
$2.61 billion
P/E Ratio
97.24
Dividend Yield
N/A
Price Target
$31.00
Consensus Rating
Moderate Buy

Company Overview

Privia Health Group, Inc. is a national physician enablement company that supports independent medical groups in delivering value-based care. Through its technology-enabled platform, the company provides administrative, clinical, and operational services designed to help physicians manage patient populations, improve care coordination, and participate in contracts with health plans and employers.

Privia’s services include practice management, electronic health record and data analytics tools, revenue-cycle support, marketing, recruiting, and other nonclinical business functions. Physicians generally retain clinical autonomy while using Privia’s platform and affiliated medical groups to coordinate care, manage costs, and pursue reimbursement arrangements that reward quality and outcomes. The company also operates Privia Medical Group organizations and supports primary care and specialty providers.

Founded in 2007, Privia Health serves physician practices and patients across multiple U.S. markets, including Virginia, Maryland, the District of Columbia, Georgia, Tennessee, Texas, and Montana. The company is headquartered in Arlington, Virginia, and became a publicly traded company on the Nasdaq under the ticker symbol PRVA in 2021. Parth Mehrotra serves as chief executive officer.

AI Generated. May Contain Errors.

Privia Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
85th Percentile Overall Score

PRVA MarketRank™: 

Privia Health Group scored higher than 85% of companies evaluated by MarketBeat, and ranked 93rd out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Privia Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on no strong buy ratings, 11 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Privia Health Group has a consensus price target of $31.00, representing about 51.8% upside from its current price of $20.42.

  • Amount of Analyst Coverage

    Privia Health Group has only been the subject of 3 research reports in the past 90 days.

  • Read more about Privia Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Privia Health Group are expected to grow by 51.85% in the coming year, from $0.27 to $0.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Privia Health Group is 97.24, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.19.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Privia Health Group is 97.24, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.25.

  • Price to Book Value per Share Ratio

    Privia Health Group has a P/B Ratio of 3.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Privia Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    4.53% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 6.29.
  • Change versus previous month

    Short interest in Privia Health Group has recently increased by 3.16%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Privia Health Group does not currently pay a dividend.

  • Dividend Growth

    Privia Health Group does not have a long track record of dividend growth.

  • News Sentiment

    Privia Health Group has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Privia Health Group this week, compared to 4 articles on an average week.
  • MarketBeat Follows

    3 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,628,256.00 in company stock.

  • Percentage Held by Insiders

    5.70% of the stock of Privia Health Group is held by insiders.

  • Percentage Held by Institutions

    94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Privia Health Group's insider trading history.
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRVA Stock News Headlines

Why I went to Mount Rushmore
A small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent.tc pixel
Truist Financial Remains a Buy on Privia Health Group (PRVA)
Privia Health Group (PRVA) Gets a Buy from Citi
See More Headlines

PRVA Stock Analysis - Frequently Asked Questions

Privia Health Group's stock was trading at $23.71 on January 1st, 2026. Since then, PRVA stock has decreased by 13.9% and is now trading at $20.42.

Privia Health Group, Inc. (NASDAQ:PRVA) released its quarterly earnings results on Thursday, August, 6th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.07 by $0.12. The business's revenue was up 21.4% on a year-over-year basis.
Read the conference call transcript
.

Privia Health Group (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Privia Health Group's top institutional shareholders include BlackRock Inc. (16.98%), Rubicon Founders LLC (4.67%), Bank of New York Mellon Corp (2.30%) and California State Teachers Retirement System (2.14%). Insiders that own company stock include Adam Boehler, William M Sullivan, Parth Mehrotra, David Mountcastle, Thomas Bartrum, Edward C Fargis, Matthew Shawn Morris and Thomas A Mccarthy.
View institutional ownership trends
.

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Privia Health Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
8/06/2026
Today
9/13/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:PRVA
CIK
1759655
Fax
N/A
Employees
1,226
Year Founded
2007

Price Target and Rating

High Price Target
$36.00
Low Price Target
$24.00
Potential Upside/Downside
+51.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.21
Trailing P/E Ratio
97.24
Forward P/E Ratio
75.63
P/E Growth
N/A
Net Income
$22.92 million
Net Margins
1.19%
Pretax Margin
2.38%
Return on Equity
3.52%
Return on Assets
2.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.62
Quick Ratio
1.62

Sales & Book Value

Annual Sales
$2.12 billion
Price / Sales
1.23
Cash Flow
$0.27 per share
Price / Cash Flow
76.51
Book Value
$6.43 per share
Price / Book
3.18

Miscellaneous

Outstanding Shares
127,730,000
Free Float
120,453,000
Market Cap
$2.61 billion
Optionable
Optionable
Beta
0.87

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:PRVA) was last updated on 9/14/2026 by MarketBeat.com Staff.
From Our Partners